BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang B, Zhang XX, Gu N. Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease. BMC Complement Med Ther 2020;20:345. [PMID: 33187508 DOI: 10.1186/s12906-020-03133-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liang Y, Liang B, Chen W, Wu XR, Liu-Huo WS, Zhao LZ. Potential Mechanism of Dingji Fumai Decoction Against Atrial Fibrillation Based on Network Pharmacology, Molecular Docking, and Experimental Verification Integration Strategy. Front Cardiovasc Med 2021;8:712398. [PMID: 34859062 DOI: 10.3389/fcvm.2021.712398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liang Y, Liang B, Wu XR, Chen W, Zhao LZ. Network Pharmacology-Based Systematic Analysis of Molecular Mechanisms of Dingji Fumai Decoction for Ventricular Arrhythmia. Evid Based Complement Alternat Med 2021;2021:5535480. [PMID: 34046076 DOI: 10.1155/2021/5535480] [Reference Citation Analysis]
3 Zhang X, Shao C, Cheng S, Zhu Y, Liang B, Gu N. Effect of Guanxin V in animal model of acute myocardial infarction. BMC Complement Med Ther 2021;21:72. [PMID: 33618704 DOI: 10.1186/s12906-021-03211-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Liang B, Zhang XX, Li R, Gu N. Guanxin V protects against ventricular remodeling after acute myocardial infarction through the interaction of TGF-β1 and Vimentin. Phytomedicine 2021;95:153866. [PMID: 34883417 DOI: 10.1016/j.phymed.2021.153866] [Reference Citation Analysis]
5 Zhang XX, Liang B, Shao CL, Gu N. Traditional Chinese Medicine Intervenes Ventricular Remodeling Following Acute Myocardial Infarction: Evidence From 40 Random Controlled Trials With 3,659 Subjects. Front Pharmacol 2021;12:707394. [PMID: 34531742 DOI: 10.3389/fphar.2021.707394] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liang B, Liang Y, Li R, Zhang H, Gu N. Integrating systematic pharmacology-based strategy and experimental validation to explore the synergistic pharmacological mechanisms of Guanxin V in treating ventricular remodeling. Bioorg Chem 2021;115:105187. [PMID: 34303037 DOI: 10.1016/j.bioorg.2021.105187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Liang B, Gu N. Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials. Front Cardiovasc Med 2021;8:702110. [PMID: 34422929 DOI: 10.3389/fcvm.2021.702110] [Reference Citation Analysis]
8 Zhu YC, Liang B, Gu N. Cellular and Molecular Mechanism of Traditional Chinese Medicine on Ventricular Remodeling. Front Cardiovasc Med 2021;8:753095. [PMID: 34926607 DOI: 10.3389/fcvm.2021.753095] [Reference Citation Analysis]
9 Liang B, Cai XY, Gu N. Marine Natural Products and Coronary Artery Disease. Front Cardiovasc Med 2021;8:739932. [PMID: 34621803 DOI: 10.3389/fcvm.2021.739932] [Reference Citation Analysis]
10 Liang B, Zhang XX, Li R, Zhu YC, Tian XJ, Gu N. Guanxin V alleviates acute myocardial infarction by restraining oxidative stress damage, apoptosis, and fibrosis through the TGF-β1 signalling pathway. Phytomedicine 2022;100:154077. [PMID: 35395567 DOI: 10.1016/j.phymed.2022.154077] [Reference Citation Analysis]